free slots with bonus fbjili com

cashspinscasino| Hot View Bio: Joint-stock company SGC001 innovative drug research and development clinical trial application was approved by the FDA

Securities Times e Company Newscashspinscasino, Rejing Biotech (688068)(688068) announced on the evening of May 27 that the company recently received a notification letter from its shareholding company Shunjing Pharmaceutical that the clinical trial application (IND) for the innovative drug SGC001 developed by Shunjing Pharmaceutical was approved by the U.S. Food and Drug Administration (FDA). SGC001 is a monoclonal antibody drug for emergency use jointly developed by the R & D team of Professor Sun Zhiwei of Shunjing Medicine and the team of Professor Du Jie of the Beijing City Institute of Cardiopulmonary and Vascular Diseases of Capital Medical University. It is suitable for emergency treatment of patients with acute myocardial infarction.

cashspinscasino| Hot View Bio: Joint-stock company SGC001 innovative drug research and development clinical trial application was approved by the FDA

Author:editor Category:Academia 浏览:9 Comments:0